Low-Intensity Physical Exercise Decreases Inflammation and Joint Damage in the Preclinical Phase of a Rheumatoid Arthritis Murine Model
- PMID: 36979423
- PMCID: PMC10046494
- DOI: 10.3390/biom13030488
Low-Intensity Physical Exercise Decreases Inflammation and Joint Damage in the Preclinical Phase of a Rheumatoid Arthritis Murine Model
Abstract
Lifestyle modifications in preclinical Rheumatoid Arthritis (RA) could delay the ongoing pathogenic immune processes and potentially prevent its onset. Physical exercise (PE) benefits RA patients; however, its impact in reducing the risk of developing RA has scarcely been studied. The objective was to describe the effects of low-intensity PE applied at the disease's preclinical phase on the joints of DBA/1 mice with collagen-induced arthritis (CIA). Twelve mice with CIA were randomly distributed into two groups: the CIA-Ex group, which undertook treadmill PE, and the CIA-NoEx, which was not exercised. The effects of PE were evaluated through clinical, histological, transcriptomics, and immunodetection analyses in the mice's hind paws. The CIA-Ex group showed lower joint inflammation and damage and a decreased expression of RA-related genes (Tnf Il2, Il10, Il12a, IL23a, and Tgfb1) and signaling pathways (Cytokines, Chemokines, JAK-STAT, MAPK, NF-kappa B, TNF, and TGF-beta). TNF-α expression was decreased by PE in the inflamed joints. Low-intensity PE in pre-arthritic CIA reduced the severity through joint down-expression of proinflammatory genes and proteins. Knowledge on the underlying mechanisms of PE in preclinical arthritis and its impact on reducing the risk of developing RA is still needed.
Keywords: at-risk arthritis; inflammation; joint damage; microarray; physical exercise; preclinical arthritis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.Arthritis Res. 1999;1(1):81-91. doi: 10.1186/ar14. Epub 1999 Oct 26. Arthritis Res. 1999. PMID: 11056663 Free PMC article.
-
MDM2 promotes rheumatoid arthritis via activation of MAPK and NF-κB.Int Immunopharmacol. 2016 Jan;30:69-73. doi: 10.1016/j.intimp.2015.11.030. Epub 2015 Dec 2. Int Immunopharmacol. 2016. PMID: 26655743
-
Characteristics of Ang-(1-7)/Mas-Mediated Amelioration of Joint Inflammation and Cardiac Complications in Mice With Collagen-Induced Arthritis.Front Immunol. 2021 May 17;12:655614. doi: 10.3389/fimmu.2021.655614. eCollection 2021. Front Immunol. 2021. PMID: 34079544 Free PMC article.
-
Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice.Arthritis Res Ther. 2019 Dec 17;21(1):292. doi: 10.1186/s13075-019-2073-x. Arthritis Res Ther. 2019. PMID: 31847895 Free PMC article.
-
Therapeutic exercise interventions in rat models of arthritis.Neurobiol Pain. 2023 Apr 25;13:100130. doi: 10.1016/j.ynpai.2023.100130. eCollection 2023 Jan-Jul. Neurobiol Pain. 2023. PMID: 37179770 Free PMC article. Review.
Cited by
-
Aqueous Extracts of Rhus trilobata Inhibit the Lipopolysaccharide-Induced Inflammatory Response In Vitro and In Vivo.Plants (Basel). 2024 Oct 10;13(20):2840. doi: 10.3390/plants13202840. Plants (Basel). 2024. PMID: 39458787 Free PMC article.
-
Hypoxia with or without Treadmill Exercises Affects Slow-Twitch Muscle Atrophy and Joint Destruction in a Rat Model of Rheumatoid Arthritis.Int J Mol Sci. 2023 Jun 5;24(11):9761. doi: 10.3390/ijms24119761. Int J Mol Sci. 2023. PMID: 37298711 Free PMC article.
-
Integrating Rehabilitation Services into Routine Care of Rheumatoid Arthritis May Reduce the Inflammatory Response: A Hospital-Based Follow-Up Study in Taiwan.Medicina (Kaunas). 2024 Nov 25;60(12):1938. doi: 10.3390/medicina60121938. Medicina (Kaunas). 2024. PMID: 39768820 Free PMC article.
-
Therapeutic potential of Coptis chinensis for arthritis with underlying mechanisms.Front Pharmacol. 2023 Aug 11;14:1243820. doi: 10.3389/fphar.2023.1243820. eCollection 2023. Front Pharmacol. 2023. PMID: 37637408 Free PMC article. Review.
-
Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases.J Clin Med. 2024 Jan 11;13(2):403. doi: 10.3390/jcm13020403. J Clin Med. 2024. PMID: 38256537 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous